The Indian Journal of Chest Diseases and Allied Sciences

Register      Login

VOLUME 58 , ISSUE 2 ( April-June, 2016 ) > List of Articles

CASE REPORT

Management of Chylothorax After Coronary Artery Bypass Grafting: Two Case Reports and Review of Literature

Kaushik Mukherjee, Ushnish Chakrabarty, Kollol Dasbakshi, Sanchita Roymukherjee, Enakshi Saha, Plaban Mukherjee

Keywords : Chylothorax, Coronary artery bypass grafting, Octreotide, Somatostatin

Citation Information : Mukherjee K, Chakrabarty U, Dasbakshi K, Roymukherjee S, Saha E, Mukherjee P. Management of Chylothorax After Coronary Artery Bypass Grafting: Two Case Reports and Review of Literature. Indian J Chest Dis Allied Sci 2016; 58 (2):131-134.

DOI: 10.5005/ijcdas-58-2-131

License: CC BY-NC 4.0

Published Online: 17-11-2022

Copyright Statement:  Copyright © 2016; The Author(s).


Abstract

Chylothorax following coronary artery bypass graft (CABG) surgery is a very rare complication and its management is debatable. Opinions vary from early aggressive management to prolonged conservative treatment. We describe two cases of post-operative chylothorax following CABG and its management with intravenous octreotide.


PDF Share
  1. Sieczka EM, Harvey JC. Early thoracic duct ligation for postoperative chylothorax. J Surg Oncol 1996;61:56–60.
  2. Kilic D, Sahin E, Gulcan O, Bolat B, Turkoz R, Hatipoglu A. Octreotide for treating chylothorax after cardiac surgery. Tex Heart Inst J 2005;32:437–9.
  3. Eldaif SM, Singh KA, Kane L, Miller JI. Postoperative chylothorax: 20 years of managing a rare complication of coronary artery bypass grafting. Chest 2009;136:35S-h-36S.
  4. Riquet M, Assouad J, D'Attellis N , Gandjbakhch I. Chylothorax and re-expansion pulmonary edema following myocardial re-vascularization: role of lymph vessel insufficiency. Interact Cardiovasc Thorac Surg 2004;3:423–5.
  5. Fahimi H, Casselman FP, Mariani MA, van Boven WJ, Knaepen PJ, van Swieten HA. Current management of postoperative chylothorax. Ann Thorac Surg 2001;71:448–50.
  6. Maldonado F, Hawkins FJ, Daniels CE, Doerr CH, Decker PA, Ryu JH. Pleural fluid characteristics of chylothorax. Mayo Clin Proc 2009;84:129–33.
  7. Staats BA, Ellefson RD, Budahn LL, Dines DE, Prakash UB, Offord K. The lipoprotein profile of chylous and nonchylous pleural effusions. Mayo Clin Proc 1980;55:700–04.
  8. Helin RD, Angeles STV, Bhat R. Octreotide therapy for chylothorax in infants and children: a brief review. Pediatr Crit Care Med 2006;7:1–5.
  9. Guillem P, Papachristos I, Peillon C, Triboulet JP. Etilefrine use in the management of post-operative chyle leaks in thoracic surgery. Interact Cardiovasc Thorac Surg 2004;3:156–60.
  10. Nakano A, Kato M, Watanabe T, Kawai N, Ota H, Hattori T, et al. OK-432 chemical pleurodesis for the treatment of persistent chylothorax. Hepatogastroenterology 1994;41:568–70.
  11. Cope C, Salem R, Kaiser LR. Management ofchylothorax by percutaneous catheterization and embolization of the thoracic duct: prospective trial. J Vasc Interv Radiol 1999;10:1248–54.
  12. Misthos P, Kanakis MA, Lioulias AG. Chylothorax complicating thoracic surgery: conservative or early surgical management? Updates Surg 2012;64:5–11.
  13. Fahimi H, Casselman FP, Mariani MA, van Boven WJ, Knaepen PJ, van Swieten HA. Current management of postoperative chylothorax. Ann Thorac Surg 2001;71:448–51.
  14. Gabbieri D, Bavutti L, Zaca F, Turinetto B, Ghidoni I. Conservative treatment of postoperative chylothorax with octreotide. Italian Heart J 2004;5:479–82.
  15. Choong CK, Martinez C, Barner HB. Chylothorax after internal thoracic artery harvest. Ann Thorac Surg 2006;81:1507–9.
  16. Weber DO, Mastro PD, Yarnoz MD. Chylothorax after myocardial revascularization with internal mammary graft. Ann Thorac Surg 1981;32:499–2.
  17. Karimi A, Salehi OA, Yazdanifard P. Chylothorax after coronary artery bypass and internalmammary artery harvesting: a case report. East Mediterr Health J 2010;16:1103–4.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.